How Best to Assess New Celiac Disease Therapies? How Best to Assess New Celiac Disease Therapies?

Two patient-reported outcome measures, and morphometric histology, are the best outcome measures for trials of celiac disease therapies, according to a new systematic review.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Gastroenterology News Source Type: news